multiple sclerosis Search Results


93
Sanguine Biosciences Inc multiple sclerosis
Multiple Sclerosis, supplied by Sanguine Biosciences Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc12607815-101-34-39?v=Sanguine+Biosciences+Inc
Average 93 stars, based on 1 article reviews
multiple sclerosis - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Novus Biologicals human brain lysates
Human Brain Lysates, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pm40730554-306-2-16?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
human brain lysates - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Novus Biologicals human brain whole tissue lysates
Patient description and tumor sample characteristics
Human Brain Whole Tissue Lysates, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc06844835-45-0-15?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
human brain whole tissue lysates - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

91
Sanguine Biosciences Inc sle
Patient description and tumor sample characteristics
Sle, supplied by Sanguine Biosciences Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/us11660302-648-7-11?v=Sanguine+Biosciences+Inc
Average 91 stars, based on 1 article reviews
sle - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare multiple sclerosis subgroup discovery and care improvements
Patient description and tumor sample characteristics
Multiple Sclerosis Subgroup Discovery And Care Improvements, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pm36861741-309-10-13?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
multiple sclerosis subgroup discovery and care improvements - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
CH Instruments multiple sclerosis
Patient description and tumor sample characteristics
Multiple Sclerosis, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc07240165-25-59-71?v=CH+Instruments
Average 90 stars, based on 1 article reviews
multiple sclerosis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare johns hopkins multiple sclerosis center
Patient description and tumor sample characteristics
Johns Hopkins Multiple Sclerosis Center, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc08863243__pone__0264452__s002-55-32-30?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
johns hopkins multiple sclerosis center - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Marburg GmbH marburg's ms
Patient description and tumor sample characteristics
Marburg's Ms, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc07158368-1141-18-18?v=Marburg+GmbH
Average 90 stars, based on 1 article reviews
marburg's ms - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare multiple sclerosis center
Patient description and tumor sample characteristics
Multiple Sclerosis Center, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc05338912-59-8-12?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
multiple sclerosis center - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Marburg GmbH acute multiple sclerosis (marburg’s type)
Demographic data in relation to pathology of the MS cases included in this study. Abbreviations: <t> CDM </t> = percentage of cerebellar cortical area affected by demyelination; <t> WMDM </t> = percentage of cerebellar white matter area affected by demyelination; M = male; F = female; AMS = acute multiple sclerosis (Marburg’s type); RRMS = relapsing/remitting MS; SPMS = secondary progressive MS; PPMS = primary progressive MS; UPMS = progressive MS with insufficient clinical information to separate between PPMS and SPMS; NA = data not available; (in AMS, focal neurological symptoms are frequently masked because of the fulminant disease evolution); +? = clinical reports only mention cerebellar involvement without specifications.
Acute Multiple Sclerosis (Marburg’s Type), supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc08095596-100-11-33?v=Marburg+GmbH
Average 90 stars, based on 1 article reviews
acute multiple sclerosis (marburg’s type) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare multiple sclerosis (ms) diseasemodifying therapies
Demographic data in relation to pathology of the MS cases included in this study. Abbreviations: <t> CDM </t> = percentage of cerebellar cortical area affected by demyelination; <t> WMDM </t> = percentage of cerebellar white matter area affected by demyelination; M = male; F = female; AMS = acute multiple sclerosis (Marburg’s type); RRMS = relapsing/remitting MS; SPMS = secondary progressive MS; PPMS = primary progressive MS; UPMS = progressive MS with insufficient clinical information to separate between PPMS and SPMS; NA = data not available; (in AMS, focal neurological symptoms are frequently masked because of the fulminant disease evolution); +? = clinical reports only mention cerebellar involvement without specifications.
Multiple Sclerosis (Ms) Diseasemodifying Therapies, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pm29536796-510-42-33?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
multiple sclerosis (ms) diseasemodifying therapies - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Precision Med Inc multiple sclerosis (ms) parkinson disease (pd) csf
Demographic data in relation to pathology of the MS cases included in this study. Abbreviations: <t> CDM </t> = percentage of cerebellar cortical area affected by demyelination; <t> WMDM </t> = percentage of cerebellar white matter area affected by demyelination; M = male; F = female; AMS = acute multiple sclerosis (Marburg’s type); RRMS = relapsing/remitting MS; SPMS = secondary progressive MS; PPMS = primary progressive MS; UPMS = progressive MS with insufficient clinical information to separate between PPMS and SPMS; NA = data not available; (in AMS, focal neurological symptoms are frequently masked because of the fulminant disease evolution); +? = clinical reports only mention cerebellar involvement without specifications.
Multiple Sclerosis (Ms) Parkinson Disease (Pd) Csf, supplied by Precision Med Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis/pmc03777607-158-2-12?v=Precision+Med+Inc
Average 90 stars, based on 1 article reviews
multiple sclerosis (ms) parkinson disease (pd) csf - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Patient description and tumor sample characteristics

Journal: Experimental Neurobiology

Article Title: LGR5 and Downstream Intracellular Signaling Proteins Play Critical Roles in the Cell Proliferation of Neuroblastoma, Meningioma and Pituitary Adenoma

doi: 10.5607/en.2019.28.5.628

Figure Lengend Snippet: Patient description and tumor sample characteristics

Article Snippet: Human brain whole tissue lysates and brain tissue slides from normal adults were obtained from Novus Biologicals (Littleton, CO, USA).

Techniques: Concentration Assay

Expression of LGR5, hnRNPA2B1, and hnRNPH3 proteins in human normal, benign meningioma, and pituitary adenoma tissues, and immunohistochemistry for LGR5 and hnRNPH3 in meningioma and pituitary adenoma tissues with immunofluorescence confocal microscopy. (A) Comparison of expression levels of LGR5, hnRNPA2B1, and hnRNPH3 between normal, benign meningioma, and pituitary adenoma by western blotting. (B) Confocal images of the human normal brain (top), meningioma (middle) and pituitary adenoma (bottom) tissues stained with antibodies against LGR5 (green) and hnRNPH3 (red). Scale bar: 20 μm. The number of LGR5 + /hnRNPH3 + cells per DAPI positive cells and hnRNPH3 + cells per LGR5 positive cells was counted and expressed as %.

Journal: Experimental Neurobiology

Article Title: LGR5 and Downstream Intracellular Signaling Proteins Play Critical Roles in the Cell Proliferation of Neuroblastoma, Meningioma and Pituitary Adenoma

doi: 10.5607/en.2019.28.5.628

Figure Lengend Snippet: Expression of LGR5, hnRNPA2B1, and hnRNPH3 proteins in human normal, benign meningioma, and pituitary adenoma tissues, and immunohistochemistry for LGR5 and hnRNPH3 in meningioma and pituitary adenoma tissues with immunofluorescence confocal microscopy. (A) Comparison of expression levels of LGR5, hnRNPA2B1, and hnRNPH3 between normal, benign meningioma, and pituitary adenoma by western blotting. (B) Confocal images of the human normal brain (top), meningioma (middle) and pituitary adenoma (bottom) tissues stained with antibodies against LGR5 (green) and hnRNPH3 (red). Scale bar: 20 μm. The number of LGR5 + /hnRNPH3 + cells per DAPI positive cells and hnRNPH3 + cells per LGR5 positive cells was counted and expressed as %.

Article Snippet: Human brain whole tissue lysates and brain tissue slides from normal adults were obtained from Novus Biologicals (Littleton, CO, USA).

Techniques: Expressing, Immunohistochemistry, Immunofluorescence, Confocal Microscopy, Comparison, Western Blot, Staining

Demographic data in relation to pathology of the MS cases included in this study. Abbreviations:  CDM  = percentage of cerebellar cortical area affected by demyelination;  WMDM  = percentage of cerebellar white matter area affected by demyelination; M = male; F = female; AMS = acute multiple sclerosis (Marburg’s type); RRMS = relapsing/remitting MS; SPMS = secondary progressive MS; PPMS = primary progressive MS; UPMS = progressive MS with insufficient clinical information to separate between PPMS and SPMS; NA = data not available; (in AMS, focal neurological symptoms are frequently masked because of the fulminant disease evolution); +? = clinical reports only mention cerebellar involvement without specifications.

Journal: Brain Pathology

Article Title: Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis

doi: 10.1111/j.1750-3639.2006.00041.x

Figure Lengend Snippet: Demographic data in relation to pathology of the MS cases included in this study. Abbreviations: CDM = percentage of cerebellar cortical area affected by demyelination; WMDM = percentage of cerebellar white matter area affected by demyelination; M = male; F = female; AMS = acute multiple sclerosis (Marburg’s type); RRMS = relapsing/remitting MS; SPMS = secondary progressive MS; PPMS = primary progressive MS; UPMS = progressive MS with insufficient clinical information to separate between PPMS and SPMS; NA = data not available; (in AMS, focal neurological symptoms are frequently masked because of the fulminant disease evolution); +? = clinical reports only mention cerebellar involvement without specifications.

Article Snippet: Abbreviations: CDM = percentage of cerebellar cortical area affected by demyelination; WMDM = percentage of cerebellar white matter area affected by demyelination; M = male; F = female; AMS = acute multiple sclerosis (Marburg’s type); RRMS = relapsing/remitting MS; SPMS = secondary progressive MS; PPMS = primary progressive MS; UPMS = progressive MS with insufficient clinical information to separate between PPMS and SPMS; NA = data not available; (in AMS, focal neurological symptoms are frequently masked because of the fulminant disease evolution); +?

Techniques: